General
Australian AstraZeneca manufacturer CSL still committed to make 50 million vaccine doses
The Australian manufacturer of the AstraZeneca COVID-19 vaccine says it still plans to fill a federal government order of 50 million doses, despite health authorities recommending a different vaccine be preferred for those under 50 years of age.
Key points:
- CSL says it remains “committed to meeting its contracted arrangements” with the Australian government and AstraZeneca
- An expert panel has advised that the Pfizer vaccine is preferred for people under 50
- The federal government expects CSL will soon start producing one million AstraZeneca doses per week
On Thursday night, the panel of experts that advises the federal government on immunisation issues recommended that Pfizer be the preferred COVID-19 vaccine for adults under 50 due to the…
-
General21 hours agoLanlan Yang pleads not guilty over Rolls-Royce crash in Sydney
-
Business20 hours agoBuying Coles shares? Here’s the dividend yield after the 8% price drop
-
Noosa News21 hours agoBrett Andrew Button appeal: Hunter Valley wedding bus crash driver loses fight to reduce sentence
-
General14 hours agoMore than 11,000 homes lose power as storms with spectacular lightning hit south-east Queensland